| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 1e-06 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | JNK Inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |